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Lower respiratory tract infections are among the top five leading causes of human
death. Fighting these infections is therefore a world health priority. Searching for
induced alterations in host gene expression shared by several relevant respiratory
pathogens represents an alternative to identify new targets for wide-range host-oriented
therapeutics. With this aim, alveolar macrophages were independently infected with
three unrelated bacterial (Streptococcus pneumoniae, Klebsiella pneumoniae, and
Staphylococcus aureus) and two dissimilar viral (respiratory syncytial virus and influenza A
virus) respiratory pathogens, all of them highly relevant for human health. Cells were also
activated with bacterial lipopolysaccharide (LPS) as a prototypical pathogen-associated
molecular pattern. Patterns of differentially expressed cellular genes shared by the
indicated pathogens were searched by microarray analysis. Most of the commonly
up-regulated host genes were related to the innate immune response and/or apoptosis,
with Toll-like, RIG-I-like and NOD-like receptors among the top 10 signaling pathways
with over-expressed genes. These results identify new potential broad-spectrum targets
to fight the important human infections caused by the bacteria and viruses studied
here.
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INTRODUCTION
According to the World Health Organization, lower respiratory
tract infections are the fourth leading cause of human death
worldwide (3.1 million deaths in 2012), only behind ischemic
heart disease, stroke and chronic obstructive pulmonary disease
(COPD) (http://www.who.int/mediacentre/factsheets/fs310/
en/). Acute respiratory infections are the most frequent cause
of visits to health services around the world, and account for
20–40% of children hospitalizations, with pneumonia being the
leading global killer of children under five (UNICEF and WHO,
20061; Forum of International Respiratory Societies, 20132)
Consequently, respiratory infections constitute an enormous
global health burden, complicated by the existence of different
etiologic agents that frequently co-infect the same individual,
the emergence of drug-resistant variants, and the emergence and
re-emergence of new human respiratory pathogens.
Infectious diseases can be regarded as the result of specific
interactions between pathogens and their hosts. Classical
approaches to combat these infections have focused on targeting
distinctive processes of each pathogen’s infectious cycle with
specific drugs. The rationale behind this approach is that
the more specific the target, the less likely the drug will
cause host toxicity. Despite the unquestionable success of this
approach in different areas, the high economic cost of developing
multiple pathogen-specific treatments and the emergence of drug
resistance have compelled searching for alternative therapeutic
approaches.
Promising alternative strategies to overcome the noted
problems of pathogen specificity and drug resistance might
arise from studies of the host response to invading pathogens.
Modulation of host genes essential for the infectivity of multiple
microorganisms is conceptually possible since distinct pathogens
confront the same host background and may converge onto
similar cellular responses (Jenner and Young, 2005). The
discovery of host gene products that might be targets of
effective drugs against multiple infectious agents, i.e., host-
oriented broad-spectrum (HOBS) drug targets, would have
several benefits with respect to treating multiple, co-infecting
microorganisms, lowering economic costs and limiting drug
resistance selection. An essential first step in the discovery of such
drug targets is to identify processes and cellular pathways altered
in common by multiple pathogens.
The identification of biological pathways induced by different
viruses or bacteria has been the topic of recent work (Zinman
et al., 2011; Smith et al., 2012, 2013; Kidane et al., 2013). Most of
these studies, however, examined separately viruses and bacteria,
and were mostly based on large-scale analysis of previously
published microarray datasets (Smith et al., 2012, 2013; Kidane
et al., 2013). In only one report, alveolar macrophages from mice
and macaque were infected in parallel with influenza A virus
(IAV),Mycobacterium tuberculosis and Francisella tularensis and
the innate immune responses were compared (Zinman et al.,




species and across the three pathogens. However, both IAV
and M. tuberculosis have mechanisms aimed to minimize the
induction of innate immunity, thus partially hiding the full-
blown of the host response (Geiss et al., 2002; Nau et al., 2002).
Therefore, data from additional microorganisms are clearly
needed to build a solid picture of a possible common response
against respiratory pathogens.
The aim of this study was to search for collective mechanisms
triggered by different respiratory pathogens when infecting
alveolar macrophages, one of the first cell types of the
innate immune system to interact with pathogens invading
the lung. Thus, the macrophage-derived cell line MH-S was
infected independently with five unrelated respiratory pathogens,
highly relevant for humans; i.e., two human viruses (IAV, and
respiratory syncytial virus, RSV) and three bacteria (Klebsiella
pneumoniae, Streptococcus pneumoniae, and Staphylococcus
aureus).
IAV is considered a major, global health threat that causes
yearly winter worldwide epidemics in humans, with 50 million
annual illnesses in the United States (Peasah et al., 2013).
Symptoms include fever, headache, cough, sore throat, nasal
congestion, sneezing and body aches. While IAV infects
individuals of all age groups, human RSV is the main cause of
lower respiratory tract infections (bronchiolitis and pneumonia)
in infants and young children, causing annually about 34 million
new episodes of acute respiratory infections (ARI) worldwide
in children younger than 5 years, with 10% of them requiring
hospital admission (Nair et al., 2010). In addition, RSV is also
a relevant pathogen among elderly and immunocompromised
adults (Falsey, 2007).
S. pneumoniae colonizes asymptomatically the human
nasopharynx in a high percentage of the population, being
the most common causative agent of acute otitis media and
community-acquired pneumonia and a major cause of bacterial
sepsis and meningitis (O’Brien et al., 2009). S. aureus is also
a commensal of the human nasopharynx and skin that causes
invasive infections particularly worrisome when caused by
methicillin-resistant (MRSA) strains which are associated
with therapeutic failure and elevated mortality (Mulcahy
and McLoughlin, 2016). Together with MRSA, of particular
concern is the mounting prevalence of infections caused by
multidrug resistant Gram-negative bacteria, K. pneumoniae
being a very significant challenge (Bengoechea, 2016). K.
pneumoniae causes a wide range of infections, including
pneumonias, urinary tract infections, bacteremias and liver
abscesses. Historically, K. pneumoniae has caused serious
infections primarily in immunocompromised individuals, but
the recent emergence and spread of hypervirulent strains have
broadened the number of people susceptible to infections to
include healthy and immunosufficient individuals (Paczosa and
Mecsas, 2016).
In order to identify possible targets for the development
of host-oriented broad-spectrum therapies, the differential
expression of cellular genes upon exposure of MH-S cells to
the above selected pathogens was examined by microarray
technology. Shared altered pathways related to apoptosis and
pathogen-specific pattern recognition receptors (PRRs) were
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identified, indicating that macrophages respond to invading
bacteria and viruses using similar ammunitions and strategies.
MATERIALS AND METHODS
Macrophage Culture
MH-S cells (ATCC R© CRL-2019TM) were originally obtained
from bronchoalveolar lavage of BALB/cj mice and were in vitro
transformed with SV40 (Mbawuike and Herscowitz, 1989). They
lack contact inhibition of growth and are trypsin-sensitive, but
they maintain typical macrophage morphology, and express cell
surface Ia and Mac-1 antigens. MH-S cells were maintained in
RPMI 1640 medium supplemented with 10% fetal bovine serum
(FBS), 4 mM L-glutamine, 100 U/ml penicillin and 100 U/ml
streptomycin. All cells were incubated at 37◦C in a 5% CO2
atmosphere.
Virus and Bacteria Strains
Table 1 shows the viruses and bacteria used to infect MH-S cells.
The Long and A2 strains of human RSV were propagated
in HEp-2 cells and purified from clarified culture supernatants
by polyethylene glycol precipitation and centrifugation in
a discontinuous sucrose gradient, as previously described
(Mbiguino and Menezes, 1991; Martínez et al., 2007).
Influenza wild type A/PR/8/34 and A/PR/8/34 lacking NS1
(A/PR/8/34 1NS1) (a gift of A. García-Sastre) viruses were
propagated in MDCK and Vero cells, respectively. Wild type
virus was titrated by plaque assay in MDCK cells and the 1NS1
mutant was titrated in MDCK-V2 cells that express the V protein
of SV5which leads to STAT1 degradation (Andrejeva et al., 2002).
S. pneumoniae D39 (NCTC 7466) is a serotype 2 strain
previously used for many studies dealing with pneumococcal
pathogenesis (Lanie et al., 2007). S. pneumoniae cells were grown
in C medium supplemented with 0.08% yeast extract at 37◦C as
previously reported (Domenech et al., 2009). S. aureus (Newman
strain) and K. pneumoniae (52145 and 43186 strains) were grown
in 5 ml of Luria Bertani medium (180 rpm, 37◦C) and harvested
in the exponential phase.
MH-S Infections and Exposure to LPS
MH-S subconfluent monolayers were either mock-infected or
infected with RSV at a multiplicity of infection (MOI) of 3 plaque
forming units (pfu) per cell. Cells were incubated with the viral
inoculum in RPMI 1640 supplemented with 2% FBS (RPMI2)
for 90min at 37◦C. After that time, the inoculum was removed
TABLE 1 | List of respiratory pathogens analyzed in this study.
Pathogen Strain Post-infection time (h)
Respiratory syncytial virus A2, Long 1, 18
Influenza virus* A/PR/8/34, ∆NS1 7
Streptococcus pneumoniae D39 (NCTC 7466) 1, 4
Klebsiella pneumoniae 121 (52145), 995 (43816) 1, 4, 8
Staphylococcus aureus Newman 1, 4
*Influenza A/PR/8/34 virus and the ∆NS1 mutant were analyzed as an outgroup of the
current study for reasons explained in the text.
and fresh RPMI2 was added. At 1 and 18 h post-infection, culture
supernatants were removed, cells were trypsinized, washed with
PBS and RNA was extracted. Infection of MH-S with influenza
virus was done similarly at a MOI of 3 pfu/cell in RPMI 1640 and
harvested 7 h after infection.
For S. aureus, S. pneumoniae and K. pneumoniae infections,
MH-S cells were incubated with bacteria at a MOI of 50
bacteria/cell for 30 min. Subsequently, cells were washed with
PBS; then, fresh medium with gentamicin (100µg/ml) and
penicillin (100 U/ml) was added to kill extracellular bacteria
and prevent further reinfections. At 1, 4, or 8 h post-infection
(Table 1), cells were harvested, and total RNA extracted and
stored at −80◦C until analysis. In addition, MH-S subconfluent
monolayers were also incubated in quadruplicate with 1 µg/ml
of smooth LPS from Escherichia coli O55B5 (Sigma-Aldrich,
St. Louis, MO, U.S.A.) or with buffer for 1 h. Then, culture
supernatants were removed and cells were scraped and washed
with PBS before RNA extraction.
RNA Isolation
Total RNA from mock-infected or infected cells was purified
with the RNeasy Minikit (Qiagen) following the manufacturer’s
instruction. Briefly, cells were lysed in the presence of guanidine-
thiocyanate containing buffer to inactivate RNases and ethanol
was added (70% final) to facilitate binding of mRNAs to RNeasy
spin column silica membranes. After washing, RNAs were
eluted from the membranes in a small volume of RNase-free
water.
Gene Expression Profiling: Sample
Labeling and Microarray Hybridizations
Gene expression profiling analyses were conducted using the
Agilent Whole Mouse Genome microarray (G4122F, Agilent
Technologies, Palo Alto, CA), representing about 44,000 mouse
genes, transcripts and controls.
One microgram of total RNA from each sample was amino-
allyl labeled and amplified using the Amino Allyl MessageAmp II
aRNA Amplification Kit (Applied Biosystems, Foster City, CA).
Aliquots (1.2 µg) of antisense amplified RNA were fluorescently
labeled using Cy3, according to manufacturer’s instructions, and
then appropriately hybridized to Agilent oligomicroarrays. Each
sample was directly hybridized on a single microarray. After
washing, microarray slides were scanned using a Gene Pix 4100A
scanner (Molecular Devices, Inc).
Microarray Data Transformation and
Normalization
Extraction of numerical data from scanned microarray images
(one channel per slide) was carried out using the GenePix Pro
software (Molecular Devices, Inc). Median intensity values for
each spot were used in subsequent analysis. Background signal
was removed by the normexp method (Silver et al., 2009) with an
offset of 50. Background-removed intensities were normalized by
quantile adjustment of all replicates involved in each comparison.
Both background removal and data normalization steps were
performed with limma package (Ritchie et al., 2015) (functions
normexp and normalizeQuantiles, respectively).
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Data Analysis
For each comparison (infected sample versus non infected
sample) with their replicates, differential expression (log Ratios)
and statistical significance values (p values) were calculated by
limma (Ritchie et al., 2015) with default parameters for one-
channel microarray data. Log Ratios were transformed to linear
Fold Changes and p values were adjusted by FDR (Benjamini and
Hochberg, 1995) to minimize the multiple testing problem.
Functional Annotation of Candidate Genes
Functional annotation of selected genes was carried out using
DAVID (Database for Annotation, Visualization and Integrated
Discovery) Bioinformatics Resources 6–7 (Huang et al., 2009a,b).
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
figures were obtained with KEGGMapper tool available at KEGG
database (Kanehisa and Goto, 2000; Du et al., 2014). Colors of
selected genes are based on log Ratios.
Microarray Data Availability
Raw and normalized data were deposited on GEO-NCBI
database with accession id GSE88825
RESULTS AND DISCUSSION
A Core of Cellular Genes Is Up-regulated in
Alveolar Macrophages by Bacterial and
Viral Respiratory Pathogens
In this report we explored the possibility of finding host
genes collectively de-regulated by various respiratory pathogens.
To this end, cells of the alveolar macrophage murine cell
line MH-S were independently infected with RSV, IAV, K.
pneumoniae, S. pneumoniae, or S. aureus (Table 1), followed
by microarray analysis of cellular gene expression at different
times after infection. In some cases, more than one strain
(RSV and K. pneumoniae) was included in the study to verify
inter-strain reproducibility. Finally, cells were also exposed
to lipopolysaccharide (LPS) as an archetypal Gram-negative
bacterial agonist.
It has been reported that the NS1 protein of IAV is a potent
inhibitor of the cellular antiviral response (Geiss et al., 2002).
Therefore, MH-S cells infected with either the wild type influenza
virus A/PR/8/34 strain or with a mutant lacking the NS1 gene
were analyzed as an outgroup and then compared with the results
from the other pathogens.
Figure 1 shows the heatmap of 32 genes that were found
commonly up-regulated (fold change, FC ≥ 2.0 and false
discovery rate, FDR ≤ 0.1) at any given time after infection with
K. pneumoniae, S. aureus, S. pneumoniae, or RSV in comparison
to mock-infected MH-S cells as a control (the list of genes is
shown in detail in Supplementary File S1). No commonly down-
regulated genes were found under these conditions (FC ≥ 2.0,
FDR ≤ 0.1).
Since the infectious cycle of different bacteria differs from
each other, two to three different post-infection time points
were selected, based on previous experience, for extraction of
cellular RNAs and subsequent microarray analysis. Enhanced
expression of certain genes was observed just 1 h after infection
but the level of up-regulation and the number of commonly
up-regulated genes increased substantially after 4 h of bacterial
infection (Figure 1). It is worth noting that not only the number
of up-regulated genes but also similarities in the patterns and
extent of certain changes among the three unrelated bacteria
were particularly striking. For instance, tumor necrosis factor
(TNF), chemokine receptor-like 2 (Ccrl2) and cholesterol 25-
hydroxylase (Ch25h) were, in that order, the three genes with
the highest level of enhanced expression. At the other extreme
2′-5′ oligoadenylate synthetase 3 (Oas3), purine-nucleoside
phosphorylase (Pnp), and ubiquitin-conjugating enzyme E2L6
(Ube2l6) were among the genes whose expression increased
just above the cut-off level of FC ≥ 2.0. Interestingly, changes
in gene expression observed after exposure of MH-S cells to
LPS resembled to great extent the changes induced by the
whole bacteria (Figure 1). Thus, changes in the genes with the
highest and lowest level of up-regulation in bacterial-infected
cells were reproduced in the LPS-treated cultures. This finding
confirms that LPSs can induce the majority of the macrophage
activation program, as similarly observed for lipoteichoic acids
and the muramyl dipeptide MurNAc-L-Ala-D-isoGlx (Nau et al.,
2002).
Previous studies indicated that alterations in gene expression
in epithelial cells infected with RSV were observed only after
extended periods of time (Martínez et al., 2007). Thus,MH-S cells
were infected with two different strains (A2 and Long) of human
RSV before harvesting for RNA extraction at 1 and 18 h post-
infection. In agreement with previous findings, almost none of
the genes shown in Figure 1 was up-regulated 1 h after infection
of MH-S cells with RSV. However, expression of the 32 genes
shown in Figure 1 was increased, at least for one of the RSV
strains, above FC ≥ 2.0 level, 18 h after infection. It is worth
noting that the changes observed with the two strains were very
similar, adding weight to the results of the analysis.
The number of commonly up-regulated genes dropped to
eight when RNA obtained from MH-S cells infected for 7 h
with the influenza virus A/PR/8/34 was included in the analysis
(Figure 1). However, this number increased to 25 when the
NS1 deletion mutant was examined (Figure 1), indicating that
ablation of the IAV gene which counteracts the host innate
response uncovered a pattern of gene expression alterations that
resembles to great extent those seen in macrophages infected by
other respiratory pathogens.
When the core of 32 up-regulated genes was sorted into
gene ontology categories, the immune response and the cell
death/apoptosis categories emerged as the biological processes
with the most significant changes in gene expression (Table 2).
Accordingly, RIG-I-like, Toll-like and NOD-like receptor
signaling pathways as well as apoptosis were among the top
10 pathways to which up-regulated genes could be assigned
(Table 3).
Due to the number of pathogens and conditions analyzed
in this study, the probability that a specific gene up-regulated
by all microorganisms could be a false positive assignment was
considered to be very low. However, substantial quantitative
differences between different pathogens could be expected at
the level of FC induction. This variability might increase
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FIGURE 1 | A core of host genes up-regulated by different respiratory bacteria and viruses. MH-S cells were infected with the bacteria and viruses indicated
at the top of each lane, for the noted periods of time. In addition, MH-S cells were also incubated with LPS for 1 hour. At the end of the incubation period, RNA was
extracted, amplified, labeled and used to hybridize Agilent Whole Mouse Genome microarrays that were analyzed as indicated in Materials and Methods. The Figure
shows the heatmap of 32 genes commonly up-regulated, considering any time point after infection by the indicated bacteria or RSV, using the following statistical
parameters: Fold Change (FC) ≥ 2 compared with mock infected controls and False Discovery Rate (FDR) ≤ 0.1. Genes are identified and displayed in alphabetical
order. The IAV and LPS results are shown detached at right since they were not used for the identification of the 32 genes listed in the Figure. Numbers refer to FC
values for each noted gene of each pathogen at the post-infection time indicated at the top. The circles indicate genes with FC ≥ 2 and FDR ≤ 0.1. Squares are
colored using the scale shown at the top of the Figure.
FDR values above the ≤ 0.1 threshold and thus decrease the
number of genes considered to be up-regulated. Therefore, in
order to enlarge the list of up-regulated genes, two additional
statistical thresholds, excluding FDR, were used to analyze the
microarray data: FC ≥ 2.0 (Supplementary File S2) and FC
≥ 1.5 (Supplementary File S3). As in Figure 1, the genes in
the supplementary files are listed in alphabetical order. The
next sections hence analyze in detail relevant aspects of the
biological processes (Table 2) and biological pathways (Table 3)
that include most of the commonly up-regulated genes of
Figure 1, but also extended to genes included in Supplementary
Files S2, S3.
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TABLE 2 | List of the top ten Gene Ontology Biological Processes over-represented in the genes that are commonly up-regulated by the respiratory
pathogens studied (FC ≥ 2, FDR ≤ 0.1).
Term Gene symbol Benjamini (P-value)
GO:0006955 Immune response DDX58, ICAM1, ICOSL, TNF, IRF7, TAP1, OAS1B, OAS3, RSAD2, FAS, CXCL10 2.4E-06
GO:0002252 Immune effector process ICAM1, ICOSL, IRF7, RSAD2, FAS 2.0E-02
GO:0012501 Programmed cell death TRAF1, CFLAR, TNF, JAK2, FAS, TNFAIP3, BIRC3 2.2E-02
GO:0002449 Lymphocyte mediated immunity ICAM1, ICOSL, IRF7, FAS 2.3E-02
GO:0009615 Response to virus DDX58, IRF7, OAS1B, RSAD2 2.3E-02
GO:0016265 Death TRAF1, CFLAR, TNF, JAK2, FAS, TNFAIP3, BIRC3 2.5E-02
GO:0042127 Regulation of cell proliferation ICOSL, TNF, JAK2, CD40, PNP, SLFN2, CXCL10 2.6E-02
GO:0008219 Cell death TRAF1, CFLAR, TNF, JAK2, FAS, TNFAIP3, BIRC3 2.6E-02
GO:0002443 Leukocyte mediated immunity ICAM1, ICOSL, IRF7, FAS 2.6E-02
GO:0006915 Apoptosis TRAF1, CFLAR, TNF, JAK2, FAS, TNFAIP3, BIRC3 2.7E-02
TABLE 3 | KEGG pathways over-represented in the genes that are commonly up-regulated by the panel of respiratory pathogens studied (FC ≥ 2,
FDR ≤ 0.1).
Term Gene symbol Benjamini (P-value)
mmu04622 RIG-I-like receptor signaling pathway DDX58, TNF, IRF7, CXCL10 2.5E-02
mmu04623 Cytosolic DNA-sensing pathway DDX58, IRF7, TREX1, CXCL10 2.7E-02
mmu04210 Apoptosis CFLAR, TNF, FAS, BIRC3 3.4E-02
mmu04620 Toll-like receptor signaling pathway TNF, IRF7, CD40, CXCL10 3.7E-02
mmu04920 Adipocytokine signaling pathway TNF, NFKBIE, JAK2 1.1E-01
mmu04621 NOD-like receptor signaling pathway TNF, TNFAIP3, BIRC3 1.1E-01
mmu05330 Allograft rejection TNF, FAS, CD40 1.2E-01
mmu04060 Cytokine-cytokine receptor interaction TNF, FAS, CD40, CXCL10 2.0E-01
mmu04650 Natural killer cell mediated cytotoxicity ICAM1, TNF, FAS 2.5E-01
mmu04514 Cell adhesion molecules (CAMs) ICAM1, ICOSL, CD40 3.2E-01
mmu05310 Asthma TNF, CD40 3.5E-01
Induction and Control of the Immune
Response
Most of the genes up-regulated by all pathogens under study
were found to be part of Gene Ontology Biological Processes
related with the innate immune response (Table 2). This response
is necessary to limit pathogen infections, but at the same time it
needs to be carefully regulated to avoid immune-mediated host
damage. Accordingly, several genes that mediate activation of
the immune response were induced by all pathogens, including
transcription factors (e.g., IRF7, Figure 1; IRF1, Supplementary
File S2 and NF-κB, Supplementary File S3) and components of
signaling pathways (e.g., TRAF1, Figure 1). Conversely, other
genes known to negatively regulate the activation state of the cell
were also found among those up-regulated in the host response
common to the bacteria and viruses tested. Among these, are:
(i) NFκBIA (Supplementary File S2) and NFκBIE (Figure 1) that
encode IκB-α and IκB-ε, respectively, and sequester NF-κB in the
cytoplasm, blocking its translocation to the nucleus (Hoffmann
et al., 2002), (ii) TRAFD1 (Figure 1), which is a negative
regulator of Toll-like receptor (TLR) and RIG-I-like signaling
pathways (Mashima et al., 2005; Sanada et al., 2008), and (iii)
the deubiquitinase TNFα induced protein 3 (TNFAIP3/A20,
Figure 1), which is a master regulator of inflammation and the
innate immune response (Catrysse et al., 2014). For instance,
TNFAIP3/A20 restricts NOD-mediated NF-κB activation by
deubiquitination of RIP2 (Hasegawa et al., 2008; Hitotsumatsu
et al., 2008) and, in addition, inhibits TLR and RIG-I signaling
that activate NF-κB and IRF3/IRF7 transcription factors (Wang
et al., 2004; Saitoh et al., 2005; Lin et al., 2006; Shembade et al.,
2010). Collectively, it was thus observed that the interaction of
pathogens with macrophages induces genes that promote the
host innate immune response, needed to control the invading
pathogen, but also genes that limit the activated state of the cell,
required once infection is resolved.
Apoptosis
Apoptosis is a mechanism of induced cell death that is highly
regulated by a complex interaction of pro- and anti-apoptotic
molecules (Fadeel and Orrenius, 2005). Genes encoding both
types of proteins were up-regulated by all pathogens in this
study (Tables 2, 3). Supplementary Figure S1 shows a diagram
of the KEEG apoptosis pathway highlighting the proteins whose
expression was enhanced in infected cells. Figure 2 is a simplified
version of the same pathway including those genes up-regulated
by the pathogens under study. Thus, Fas cell surface death
receptor (Fas), a key molecule in initiating caspase-mediated
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FIGURE 2 | Apoptosis pathway. This pathway is a simplified version of the Apoptosis pathway from the Kyoto Encyclopedia of Genes and Genomes (KEGG),
shown in Supplementary Figure S1. Only those parts of the KEGG pathway that are relevant for this study are shown in the Figure. Host cell genes commonly
up-regulated by K. pneumoniae, S. pneumoniae, S. aureus and RSV are highlighted in red and yellow border (FC ≥ 2, FDR ≤ 0.1), red (FC ≥ 2, no FDR), or brown (FC
≥ 1.5, no FDR), depending on the statistical parameters being considered. This color-code is also used in Supplementary Figures S1–S4 and in Figures 3–5.
apoptosis, was up-regulated but, at the same time, baculoviral
IAP repeat containing 3 (BIRC3/cIAP2, IAP in Figure 2) and
FADD-Like apoptosis regulator (CFLAR/FLIP, FLIP in Figure 2),
both having anti-apoptotic functions, were also up-regulated
(Figure 2).
The extrinsic or death receptor-mediated pathway of
apoptosis is activated by cytokine type receptors for tumor
necrosis factor (TNF), TNF-related apoptosis-inducing ligand
(TRAIL) and Fas ligand (FasL) (Fadeel and Orrenius, 2005).
The binding of ligands to death receptors triggers intracellular
signaling that results in the activation of a cascade of caspases
within the cell that finally leads to apoptosis (Fadeel and
Orrenius, 2005). Figure 2 shows that production of TNFα
and Fas receptor was enhanced by all pathogens under study,
indicating that the death receptor route to apoptosis is an
important host response to these invading pathogens. This
pathway is important for the maintenance of tissue homeostasis,
especially in the context of immune system function (Danial and
Korsmeyer, 2004).
In contrast, anti-apoptotic genes were also up-regulated by
all pathogens examined (Figure 2). Thus, CFLAR/FLIP (FLIP
in Figure 2), which is an inhibitor of the extrinsic apoptotic
signaling by preventing caspase-8 recruitment upon ligation of
Fas, was markedly up-regulated (Fadeel and Orrenius, 2005).
Additionally, BIRC3/cIAP2 (IAP in Figure 2) which binds TNF-
associated factor 2 (TRAF2) in the TNF receptor 1- and 2-
associated complexes, where it suppresses caspase-8 activation
and apoptosis, was also up-regulated (Wang et al., 1998, 2008).
Thus, CFLAR/FLIP and BIRC3/cIAP2 are two examples of
anti-apoptotic genes up-regulated in the host response common
to all the investigated pathogens.
Both pro- and anti-apoptotic genes were also up-regulated by
LPS alone in this study (Figure 1), in consonance with previous
reports showing that stimulation of alveolar macrophages with
LPS in concert with IFN-γ induces the expression of genes related
to apoptosis (Derlindati et al., 2015).
Overall, the results obtained evidence the occurrence of a
subtle but complex equilibrium between pro- and anti-apoptotic
signals during host-pathogen interaction. Apoptosis is usually
beneficial for the host, since apoptotic clearance of infected cells
can inhibit microbial replication and propagation (Lamkanfi
and Dixit, 2010). In addition, tissue injury is reduced with
this type of cell death. While suppression of apoptosis may
facilitate replication and proliferation of intracellular pathogens
(Clark and Maurelli, 2007), viruses and bacteria can also induce
apoptosis to eliminate cells required for a protective immune
response (Suzuki et al., 2005). Indeed, in certain infections,
apoptosis is first inhibited to facilitate replication of the pathogen
and later induced by the host to eliminate the infected cells.
Hence, the up-regulated host genes of Figure 2 may represent
some of the key players in this arms race between the host and
the invading pathogen.
Pathogen Recognition Receptors and
Signaling Pathways
Pathogen recognition is the first step in the cascade of cellular
events leading to the host defense response. Bacteria and viruses
are recognized by different PRRs. However, we found that genes
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from the three major PRRs pathways (Toll-like, RIG-I-like and
NOD-like) were induced by all the pathogens under study
(Table 3).
Toll-Like Receptors (TLRs) Signaling Pathway
TLRs are transmembrane proteins with an extracellular or
intra-vesicular domain that mediate recognition of pathogen-
associated molecular patterns (PAMPs) and a cytoplasmic
domain that initiates downstream signaling (Kumar et al., 2009).
To date, 10 TLRs have been identified in humans and 13 in
mice. TLRs 1–9 are conserved in both species. According to their
cellular localization, TLRs have been classified in two groups: cell
surface expressed (TLR1, 2, 4, 5, 6, and 11) and intracellularly
expressed (TLR3, 7, 8, and 9). It has been described that
the former group senses primarily bacterial wall components,
whereas the latter group is involved in the recognition of viral
and bacterial nucleic acids (Kumar et al., 2011).
Toll-like receptor 2 (TLR2) was the only TLR induced by
all pathogens tested in this study (Figure 3 and Supplementary
Figure S2). TLR2 has been reported to recognize a wide range
of PAMPs, including bacterial lipoproteins, peptidoglycans and
lipoteichoic acids as well as fungi and viral proteins (Olive,
2012; Lester and Li, 2014). TLR2 is a cell surface receptor
expressed in immune cells such as macrophages that signals
through the adapter molecule MyD88 to activate NF-κB for
transcription of innate immune genes (Figure 3). It has been
considered for a long time that activation of TLR2 does not
induce interferon (IFN) production. However, it has also been
reported that in certain monocytes TLR2 can induce type I IFN
in response to viral and bacterial infections through IRF3 and
IRF7 activation (Barbalat et al., 2009; Stack et al., 2014). In
our study, NF-κB, IRF7 and IFN-β genes were up-regulated by
all pathogens tested (Figure 3). Other inflammatory cytokines
such as TNFα and CXCL10/IP10 were also up-regulated, as well
as the gene encoding the CD40 (cluster of differentiation 40)
receptor, necessary for macrophage activation (Figure 3). Thus,
TLR2 overexpression in macrophages seems to contribute to
recognition of respiratory viruses and bacteria and initiation of
the early innate immune response.
RIG-I-Like Receptors (RLRs) Signaling Pathway
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (DDX58 /RIG-I)
is also part of the common host response against the respiratory
pathogens analyzed in this report (Figure 4 and Supplementary
Figure S3). RIG-I is a cytosolic PRR involved in the recognition
of pathogen-specific 5′-di or -triphospate RNA (Hornung et al.,
2006; Pichlmair et al., 2006; Goubau et al., 2014), leading to
activation of IRF7 and subsequent transcription of IFN-β and
other immune defense genes (Patel and García-Sastre, 2014).
RIG-I is considered to be essential for the innate immune
response against many viruses by recognizing blunt-ended base-
paired RNAs with a 5′-triphosphate in their genome or in
replication intermediates (Kato et al., 2006; Rehwinkel et al.,
2010; Weber et al., 2013). However, recent reports have shown
that RIG-I is also able to sense bacterial mRNA that translocates
to the cytosol (Abdullah et al., 2012; Hagmann et al., 2013;
Schmolke et al., 2014). These mRNAs are uncapped and 5′-
triphosphorylated. Therefore, the enhanced expression of RIG-I,
IRF7, IFN-β, TNFα, and CXCL10/IP10 in MH-S cells infected
by all the pathogens examined in the present study extends
previous findings and emphasizes a central role of this signaling
pathway for triggering the innate immune response against both
bacteria and viruses (Figure 4). It is worth noting that RIG-I was
not induced in MH-S macrophages exposed to LPS (Figure 1)
suggesting that RIG-I induction in this cell type may require
intracellular uptake of the invading pathogen.
iii) NOD-Like Receptors (NLRs) Signaling Pathways
Nucleotide-binding oligomerization domain-containing 2
(NOD2) is another cytosolic PRR that was also found to be
up-regulated in the common host-transcriptional response to all
FIGURE 3 | Toll-like receptor signaling pathway. This is a simplified version of the KEGG pathway, shown in Supplementary Figure S2.
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FIGURE 4 | RIG-I-like receptor signaling pathway. This is a simplified version of the KEEG pathway, shown in Supplementary Figure S3.
FIGURE 5 | NOD-like receptor signaling pathway. This is a simplified version of the KEGG pathway, shown in Supplementary Figure S4.
the pathogens examined (Figure 5 and Supplementary Figure
S4). NOD2 expression seems to be restricted to macrophages,
neutrophils, dendritic and bronchial cells (Qiu et al., 2013;
Leissinger et al., 2014), where it recognizes bacterial and viral
components triggering the activation of NF-κB signaling that
leads to expression of hundreds of genes involved in the innate
immune response (Girardin et al., 2003; Inohara et al., 2003).
NOD2 has been shown to sense several respiratory bacteria
(Opitz et al., 2004; Ferwerda et al., 2005; Kapetanovic et al., 2010;
Davis et al., 2011) and to respond to RSV ssRNA, triggering
activation of IRF3 (Sabbah et al., 2009). Furthermore, NOD2
interacts with 2′,5′-oligoadenylate synthetase type 2 (OAS2) and
activates RNase L, which hydrolyzes viral RNA (Dugan et al.,
2009; Ting et al., 2010).
In addition to NOD2, the receptor-interacting serine-
threonine kinase 2 (RIPK2/RIP2, RIP2 in Figure 5), a key adaptor
molecule of the NOD-like receptor signaling pathway, was also
found up-regulated in this study (Figure 5). It is worth noting
that RIP2 is also important for the activation of the NF-kB and
MAPK pathways, as well as for induction of apoptosis (McCarthy
et al., 1998; Girardin et al., 2001; Park et al., 2007;Windheim et al.,
2007; Magalhaes et al., 2011).
Apoptosis and Immune Signaling
Pathways Are Interconnected
Programmed cell death and immune pathways induced by
pathogens are closely intertwined and frequently one pathway
is replaced by the other in a coordinated battle inside the host
for pathogen survival versus elimination (Blander, 2014). In this
report, several genes involved in both apoptosis and immune
signaling pathways, such as IAP, CFLAR/FLIP and RIPK2/RIP2,
were up-regulated by all pathogens tested (Figures 2, 5). As
indicated by their name, the inhibitors of apoptosis (IAP) were
first described as proteins with anti-apoptotic functions by
interfering with the proteolytic activity of caspases (Figure 2).
More recently, however, the IAPs have been shown to regulate
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inflammatory and innate immune signaling pathways through
their ubiquitin-ligase activities (Gyrd-Hansen and Meier, 2010;
Beug et al., 2012; Estornes and Bertrand, 2015). In addition,
CFLAR/FLIP, which inhibits caspase-8 and suppresses apoptosis
(Figure 2), has also been shown to activate ERK and increase
NF-κB activation in T cells, and to inhibit myeloid cell innate
signaling (Kataoka et al., 2000; Wu et al., 2015). Finally,
RIPK2/RIP2, which activates NF-κB and MAPKs through
binding to NOD2 (Figure 5), has also been shown to induce
apoptosis (McCarthy et al., 1998; Thome et al., 1998).
Future Developments
Some of the up-regulated genes identified in this study participate
in several of the pathways listed in Table 3 and illustrated in
Figures 2–5, indicating a high degree of interconnection and
possible redundancy of the host response to viral and bacterial
pathogens. Overexpression of some of the gene-products listed in
Files S1-S3 have been reported by a number of laboratories using
different techniques for quantitation of protein levels. To name a
few examples, increased amounts of CXCL10 were demonstrated
by Luminex analysis in the supernatant of murine macrophages
infected with IAV (Zinman et al., 2011) and increased INF-
β levels have been detected by western blots in macrophages
infected with RSV (Pokharel et al., 2016) or by ELISA in the
supernatant of cells infected with S. pneumoniae (Rogers et al.,
2003). Therefore, it is likely that the up-regulation of genes
listed in Files S1-S3 will be reflected in overexpression of the
respective gene products, something that requires further in-
depth proteomic analysis. It is worth mentioning, however,
that modulation of protein activity may also occur by post-
translational modifications that could not be detected by
microarray analysis. Hence the gene products highlighted in
Figures 2–5 may be only a subset of those implicated in the host
response to respiratory pathogens. Nevertheless, the up-regulated
genes can be considered as spotlights of the host response and
thus first choice for further proteomic and functional studies
aimed to unravel the intricacies of the macrophage response to
invading respiratory pathogens.
The up-regulated genes identified in this study may also be
used in the search of new biological or chemical compounds to
fight respiratory infections in at least three different directions:
(1) Discovery of new drugs with therapeutic potency against a
wide range of respiratory pathogens; as it has been recently
documented for IRF3 agonists that have demonstrated
antiviral activity against members of the Flaviviridae (west
Nile virus), Filoviridae (Ebola virus), Orthomyxoviridae
(IAV), Arenaviridae (Lassa virus), and Paramyxoviridae
(RSV) families (Pattabhi et al., 2015).
(2) Modulation of the inflammatory response. Some of the
most severe pathological symptoms of respiratory infections
are commonly caused by inappropriate inflammatory
responses. As recently summarized (Estornes and
Bertrand, 2015), it has been found that some members
of the antiapopototic protein (IAP) family modulate
the NOD-like responses to intracellular bacteria and
influence the formation of cytoplasmic inflammasomes.
In a similar manner, modulation of other up-regulated
genes shown in Figures 1–5 might contribute to control
the undesirable inflammatory responses associated with
respiratory infections. In this respect, it has been shown
that up-regulation of TNFAIP3/A20 down-regulates the
NF-κB-mediated innate immune response (Catrysse et al.,
2014).
(3) Vaccine development. TLR ligands have recently found a
renovated impulse as vaccine adjuvants (or co-adjuvants)
(review by Coffman et al., 2010). Some recently licensed
adjuvants (e.g., oil-in-water emulsions, such as MF59 and
AS03) that modulate innate immune responses have been
shown not only to enhance the protective antibody response
but additionally to influence the polarization of this response
toward a Th1 or Th2 phenotype or influence mucosal
immunity (Gutjahr et al., 2016). Indeed, members of nearly
all of the PRR families are potential targets for adjuvants,
hence new opportunities are opened to test ligands of the
up-regulated gene-products identified in this study as new
vaccine adjuvants.
CONCLUSIONS
We have identified more than 30 cellular genes whose expression
is significantly enhanced in amacrophage cell line experimentally
exposed to different bacteria and viruses of clinical relevance.
This approach overcomes possible pitfalls when comparing
datasets obtained from studies using seemingly unrelated
experimental conditions. While viruses, such as IAV and RSV,
are obligatory intracellular parasites, the life cycles of the three
bacteria used in this study are mostly extracellular. However,
macrophage internalization of S. pneumoniae (Gordon et al.,
2000), K. pneumoniae (Cano et al., 2015), and S. aureus (Koziel
et al., 2009) has been reported, as well as bacteria survival during
several hours/days inside the cell. The experimental conditions
used in this work did not allow us to distinguish between the
effects triggered by the interactions of the respective pathogens
with the target cell before or after internalization, something that
merits future investigations.
The up-regulated genes shown in Figure 1 are part of an
ostensible core of the cell response to bacterial and viral
pathogens which is expanded by other genes included in
Supplementary Files S2, S3. There are two essential components
in these host-pathogen interactions shared by respiratory viruses
and bacteria: (i) recognition of the invading pathogens by
collective PRRs and (ii) induction of apoptosis. Both components
are intimately integrated to ensure a better control of the
infecting microorganisms. The identification of genes up-
regulated by different respiratory pathogens reported here
should facilitate the search of new host-oriented broad-spectrum
medicines.
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